Switzerland's drugmaker Roche has acquired US-based privately held company Bina Technologies, for an undisclosed amount.
Bina provides big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets.
Roche will integrate the acquired business into its sequencing unit, and it will continue to focus on development of their genomic analysis solution.
Bina Technologies founder and CEO Narges Bani Asadi said: "Roche’s acquisition of Bina is a great validation of our work and technology. It is also an indication of how informatics and data science are going to play a major role in the future of medicine.
"We found great alignment between our company’s vision and values, and we are very excited about the possibilities of working with Roche’s global team and serving the academic and translational and clinical research markets together in the future."
Bina noted that its genomic management solution, the Bina-GMS, is expected to improve the speed and cost of genomic analyses as well as its platform was recently selected by the US Department of Veterans Affairs (VA) to provide whole genome, whole whole exome, and SNP Chip DNA data analysis as part of the VA’s Million Veteran Program (MVP).